Ozempic-maker Novo Nordisk accuses rival Eli Lilly of false advertising BBCGLP-1 ad war spills into court as Novo Nordisk alleges Eli Lilly ignores science The Washington PostWeight-loss drug maker sues rival over which GLP-1 sheds the most pounds The IndependentNovo sues Lilly, claiming misleading ads in weight-loss drug battle ReutersNovo Nordisk Says It’s Suing Eli Lilly Over Weight-Loss Ads Bloomberg.com